{"id":37504,"date":"2023-01-01T00:00:00","date_gmt":"2023-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/"},"modified":"2023-01-01T00:00:00","modified_gmt":"2023-01-01T00:00:00","slug":"influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/","title":{"rendered":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study &#8211; FRONTIERS IN ENDOCRINOLOGY"},"content":{"rendered":"<p>de Lucas, MDG; Caballero, I; Fern\u00e1ndez-Garc\u00eda, JC; Dom\u00ednguez-Rodr\u00edguez, M; Moreno-Moreno, P; Jim\u00e9nez-Mill\u00e1n, A; Botana-L\u00f3pez, M; Avil\u00e9s, B; Merino-Torres, JF; Soto, A; Tejera, C; Morales, C &#8211; 2023 &#8211; 10.3389\/fendo.2023.1240279<\/p>\n","protected":false},"excerpt":{"rendered":"<p>de Lucas, MDG; Caballero, I; Fern\u00e1ndez-Garc\u00eda, JC; Dom\u00ednguez-Rodr\u00edguez, M; Moreno-Moreno, P; Jim\u00e9nez-Mill\u00e1n, A; Botana-L\u00f3pez, M; Avil\u00e9s, B; Merino-Torres, JF; Soto, A; Tejera, C; Morales, C &#8211; 2023 &#8211; 10.3389\/fendo.2023.1240279<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1578],"tags":[],"class_list":["post-37504","post","type-post","status-publish","format-standard","hentry","category-publicaciones-a-01"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima\" \/>\n<meta property=\"og:description\" content=\"de Lucas, MDG; Caballero, I; Fern\u00e1ndez-Garc\u00eda, JC; Dom\u00ednguez-Rodr\u00edguez, M; Moreno-Moreno, P; Jim\u00e9nez-Mill\u00e1n, A; Botana-L\u00f3pez, M; Avil\u00e9s, B; Merino-Torres, JF; Soto, A; Tejera, C; Morales, C - 2023 - 10.3389\/fendo.2023.1240279\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-01T00:00:00+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study &#8211; FRONTIERS IN ENDOCRINOLOGY\",\"datePublished\":\"2023-01-01T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/\"},\"wordCount\":61,\"commentCount\":0,\"articleSection\":[\"Publicaciones - A-01\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/\",\"name\":\"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2023-01-01T00:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study &#8211; FRONTIERS IN ENDOCRINOLOGY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/","og_locale":"es_ES","og_type":"article","og_title":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima","og_description":"de Lucas, MDG; Caballero, I; Fern\u00e1ndez-Garc\u00eda, JC; Dom\u00ednguez-Rodr\u00edguez, M; Moreno-Moreno, P; Jim\u00e9nez-Mill\u00e1n, A; Botana-L\u00f3pez, M; Avil\u00e9s, B; Merino-Torres, JF; Soto, A; Tejera, C; Morales, C - 2023 - 10.3389\/fendo.2023.1240279","og_url":"https:\/\/ibima.eu\/es\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/","og_site_name":"Ibima","article_published_time":"2023-01-01T00:00:00+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study &#8211; FRONTIERS IN ENDOCRINOLOGY","datePublished":"2023-01-01T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/"},"wordCount":61,"commentCount":0,"articleSection":["Publicaciones - A-01"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/","url":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/","name":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study - FRONTIERS IN ENDOCRINOLOGY - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2023-01-01T00:00:00+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/influence-of-chronic-kidney-disease-and-its-severity-on-the-efficacy-of-semaglutide-in-type-2-diabetes-patients-a-multicenter-real-world-study-frontiers-in-endocrinology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study &#8211; FRONTIERS IN ENDOCRINOLOGY"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/es\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/37504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=37504"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/37504\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=37504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=37504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=37504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}